재정 지원 요구사항을 통해 공개된 자료 - Roland R. Griffiths자세히 알아보기
제공된 곳이 없음: 5
Substance abuse: caffeine use disorders
RR Griffiths, CJ Reissig
Psychiatry, 1019-1040, 2008
재정 지원 요구사항 정책: US National Institutes of Health
Past, Present, and Future of Psychedelics: A Psychedelic Medicine Roundtable Discussion
PS Hendricks, CD Nichols, KA Cunningham, MA Geyer, R Griffiths, ...
Psychedelic Medicine 1 (1), 2-11, 2023
재정 지원 요구사항 정책: US National Institutes of Health
Substance use and addictive disorders: Caffeine
SE Meredith, RR Griffiths
Psychiatry, 1435-1457, 2015
재정 지원 요구사항 정책: US National Institutes of Health
Impact of Psilocybin on Peripheral Cytokine Production
D DiRenzo, FS Barrett, J Perin, E Darrah, L Christopher-Stine, RR Griffiths
Psychedelic Medicine, 2024
재정 지원 요구사항 정책: US National Institutes of Health
Psychedelic agents for treatment-resistant depression
N Gukasyan, RR Griffiths
Managing Treatment-Resistant Depression, 221-235, 2022
재정 지원 요구사항 정책: US National Institutes of Health
제공된 곳이 있음: 96
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
RR Griffiths, MW Johnson, MA Carducci, A Umbricht, WA Richards, ...
Journal of psychopharmacology 30 (12), 1181-1197, 2016
재정 지원 요구사항 정책: US National Institutes of Health
Caffeinated energy drinks—a growing problem
CJ Reissig, EC Strain, RR Griffiths
Drug and alcohol dependence 99 (1-3), 1-10, 2009
재정 지원 요구사항 정책: US National Institutes of Health
Human hallucinogen research: guidelines for safety
MW Johnson, WA Richards, RR Griffiths
Journal of psychopharmacology 22 (6), 603-620, 2008
재정 지원 요구사항 정책: US National Institutes of Health
Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later
RR Griffiths, WA Richards, MW Johnson, UD McCann, R Jesse
Journal of psychopharmacology 22 (6), 621-632, 2008
재정 지원 요구사항 정책: US National Institutes of Health
Effects of psilocybin-assisted therapy on major depressive disorder: a randomized clinical trial
AK Davis, FS Barrett, DG May, MP Cosimano, ND Sepeda, MW Johnson, ...
JAMA psychiatry 78 (5), 481-489, 2021
재정 지원 요구사항 정책: US National Institutes of Health
Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction
MW Johnson, A Garcia-Romeu, MP Cosimano, RR Griffiths
Journal of psychopharmacology 28 (11), 983-992, 2014
재정 지원 요구사항 정책: US National Institutes of Health
Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects
RR Griffiths, MW Johnson, WA Richards, BD Richards, U McCann, ...
Psychopharmacology 218, 649-665, 2011
재정 지원 요구사항 정책: US National Institutes of Health
Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness
KA MacLean, MW Johnson, RR Griffiths
Journal of psychopharmacology 25 (11), 1453-1461, 2011
재정 지원 요구사항 정책: US National Institutes of Health
Long-term follow-up of psilocybin-facilitated smoking cessation
MW Johnson, A Garcia-Romeu, RR Griffiths
The American journal of drug and alcohol abuse 43 (1), 55-60, 2017
재정 지원 요구사항 정책: US National Institutes of Health
Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction
A Garcia-Romeu, R R. Griffiths, M W. Johnson
Current drug abuse reviews 7 (3), 157-164, 2014
재정 지원 요구사항 정책: US National Institutes of Health
Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin
FS Barrett, MW Johnson, RR Griffiths
Journal of psychopharmacology 29 (11), 1182-1190, 2015
재정 지원 요구사항 정책: US National Institutes of Health
Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and …
RR Griffiths, MW Johnson, WA Richards, BD Richards, R Jesse, ...
Journal of psychopharmacology 32 (1), 49-69, 2018
재정 지원 요구사항 정책: US National Institutes of Health
Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences
TM Carbonaro, MP Bradstreet, FS Barrett, KA MacLean, R Jesse, ...
Journal of psychopharmacology 30 (12), 1268-1278, 2016
재정 지원 요구사항 정책: US National Institutes of Health
Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function
MW Johnson, PS Hendricks, FS Barrett, RR Griffiths
Pharmacology & therapeutics 197, 83-102, 2019
재정 지원 요구사항 정책: US National Institutes of Health
Factor analysis of the mystical experience questionnaire: A study of experiences occasioned by the hallucinogen psilocybin
KA MacLean, JMS Leoutsakos, MW Johnson, RR Griffiths
Journal for the scientific study of religion 51 (4), 721-737, 2012
재정 지원 요구사항 정책: US National Institutes of Health
발행인 및 자금 지원 정보는 컴퓨터 프로그램에서 자동으로 결정됩니다.